Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 12, 2026Cardiology in Review

Obesity and Atrial Fibrillation: Epidemiology, Mechanisms, and Therapeutic Implications in the Era of Metabolic Therapies

View Full Paper
Ask AI
Bookmark
Share

Key result

Obesity increases AF incidence and progression while weight loss and metabolic therapies reduce AF burden.

Why the study?

Obesity is a major modifiable risk factor contributing to the rising global prevalence of AF, inducing atrial cardiomyopathy through distinct mechanisms and serving as a critical therapeutic target.

Design

Structured nonsystematic literature review

Authors

HZHamza Zine-eddineMelun HospitalWAWissam AlamMelun HospitalNLNicolas LelloucheCentre Hospitalier Universitaire Henri-Mondor

Discussion

Loading...

Member takes

Implication

Weight loss should be prioritized in obese AF patients; confirms graded BMI-AF link and therapeutic potential of bariatric surgery or GLP-1 agonists.

Key Points

  • The review aims to explore the relationship between obesity and atrial fibrillation, emphasizing mechanisms and therapeutic interventions.
  • Structured nonsystematic review of literature with keywords related to obesity and AF.
  • Focus on epidemiological studies, mechanistic investigations, and randomized controlled trials.
  • Analysis of large population cohorts and recent high-impact publications.
  • Evidence shows a graded relationship between increasing body mass index and AF incidence and progression.
  • Sustained weight loss significantly reduces AF burden and improves rhythm control.
  • Bariatric surgery and glucagon-like peptide-1 receptor agonists show potential as effective therapeutic options.

PICO

P
Population
Atrial Fibrillation and Obesity
E
Exposure / Comparator
Obesity
O
Primary Outcome
Incidence, progression, and recurrence of atrial fibrillation

Obesity is a central modifiable risk factor for atrial fibrillation, and integrated management of weight and metabolic factors, including bariatric surgery and GLP-1 receptor agonists, offers potential to improve outcomes.

Limitations

  • Further research is needed to clarify the direct atrial effects of metabolic therapies.

Cite This Study

Zine-eddine et al. (2026) conducted a review in Atrial Fibrillation and Obesity. Obesity was evaluated on Incidence, progression, and recurrence of atrial fibrillation. Obesity demonstrates a graded relationship with the incidence, progression, and recurrence of atrial fibrillation, while sustained weight loss and metabolic therapies reduce AF burden.

synapsesocial.com/papers/6a2ba3748101cf8926f022e1https://doi.org/10.1097/crd.0000000000001332
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of the Autonomic Nervous System in Atrial Fibrillation2014 · 796 citations
  2. 2Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.1994 · 1,077 citations
  3. 3Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity2015 · 475 citations
  4. 4Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects2016 · 203 citations
  5. 5Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines2013 · 597 citations